... and no use reporting you for being a thoughtless and biased investor who labels posts as stupid if they do not copy nine-year-old abstracts by researchers who have nothing to do with Prana.
BTW the UK and Europe will do no negotiating. It is up to the sponsor to present data of a worthwhile therapeutic and to following the regulators' agenda to a T. If that is not done, another POOF.
I am very happy that you will waste no more time on my rubbish. Promise?
Approved drugs with CNS demyelination side effect., page-28
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17737 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 27350837 | 19 |
View Market Depth
| Last trade - 11.50am 15/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |
Day chart unavailable